Latest Insider Transactions at Teladoc Health, Inc. (TDOC)
This section provides a real-time view of insider transactions for Teladoc Health, Inc. (TDOC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Teladoc Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Teladoc Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 02
2024
|
Nikolaos P. Nanis Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
442
-0.6%
|
$3,978
$9.39 P/Share
|
|
Jul 01
2024
|
Nikolaos P. Nanis Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,233
+1.65%
|
-
|
|
Jun 04
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
468
-1.69%
|
$5,148
$11.04 P/Share
|
|
Jun 03
2024
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
4,015
-8.87%
|
$44,165
$11.16 P/Share
|
|
Jun 03
2024
|
Nikolaos P. Nanis Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
1,040
-1.42%
|
$11,440
$11.16 P/Share
|
|
Jun 03
2024
|
James L. Cave INTERIM CAO |
SELL
Open market or private sale
|
Direct |
854
-6.41%
|
$9,394
$11.16 P/Share
|
|
Jun 03
2024
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
2,096
-3.37%
|
$23,056
$11.16 P/Share
|
|
Jun 03
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,790
-5.94%
|
$19,690
$11.16 P/Share
|
|
Jun 03
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,122
-3.89%
|
$12,342
$11.16 P/Share
|
|
Jun 03
2024
|
Laizer Kornwasser PRESIDENT, ENTERPRISE GROWTH |
SELL
Open market or private sale
|
Direct |
4,812
-5.04%
|
$52,932
$11.16 P/Share
|
|
Jun 03
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
4,246
-5.8%
|
$46,706
$11.16 P/Share
|
|
Jun 03
2024
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
1,627
-4.14%
|
$17,897
$11.16 P/Share
|
|
Jun 03
2024
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
1,807
-4.15%
|
$19,877
$11.16 P/Share
|
|
Jun 03
2024
|
Mala Murthy ACTING CEO, CFO |
SELL
Open market or private sale
|
Direct |
8,807
-10.06%
|
$96,877
$11.16 P/Share
|
|
May 31
2024
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
7,803
+5.67%
|
-
|
|
May 31
2024
|
Nikolaos P. Nanis Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,854
+0.97%
|
-
|
|
May 31
2024
|
James L. Cave INTERIM CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,885
+5.49%
|
-
|
|
May 31
2024
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,768
+3.06%
|
-
|
|
May 31
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,920
+5.38%
|
-
|
|
May 31
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,407
-10.56%
|
$37,477
$11.21 P/Share
|
|
May 31
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,117
+4.65%
|
-
|
|
May 31
2024
|
Laizer Kornwasser PRESIDENT, ENTERPRISE GROWTH |
BUY
Exercise of conversion of derivative security
|
Direct |
9,352
+4.71%
|
-
|
|
May 31
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,313
+5.43%
|
-
|
|
May 31
2024
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
BUY
Exercise of conversion of derivative security
|
Direct |
5,504
+4.62%
|
-
|
|
May 31
2024
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,023
+3.81%
|
-
|
|
May 31
2024
|
Mala Murthy ACTING CEO, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,804
+4.55%
|
-
|
|
May 23
2024
|
Karen L Daniel Director |
SELL
Open market or private sale
|
Direct |
9,834
-21.0%
|
$108,174
$11.9 P/Share
|
|
May 22
2024
|
Catherine Jacobson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,834
+32.53%
|
-
|
|
May 22
2024
|
Karen L Daniel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,834
+17.36%
|
-
|
|
May 22
2024
|
Thomas Mckinley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,834
+29.0%
|
-
|
|
May 22
2024
|
David B Snow Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,834
+12.87%
|
-
|
|
May 22
2024
|
David L Shedlarz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,834
+39.9%
|
-
|
|
May 17
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-3.82%
|
$12,000
$12.83 P/Share
|
|
May 02
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,691
-11.24%
|
$44,292
$12.69 P/Share
|
|
May 02
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
5,793
-8.2%
|
$69,516
$12.69 P/Share
|
|
May 02
2024
|
Laizer Kornwasser PRESIDENT, ENTERPRISE GROWTH |
SELL
Open market or private sale
|
Direct |
10,411
-10.79%
|
$124,932
$12.69 P/Share
|
|
May 01
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,244
+23.77%
|
-
|
|
May 01
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,319
+13.8%
|
-
|
|
May 01
2024
|
Laizer Kornwasser PRESIDENT, ENTERPRISE GROWTH |
BUY
Exercise of conversion of derivative security
|
Direct |
20,198
+17.31%
|
-
|
|
Apr 17
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-3.68%
|
$13,000
$13.21 P/Share
|
|
Apr 02
2024
|
Nikolaos P. Nanis Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
461
-0.65%
|
$6,454
$14.31 P/Share
|
|
Apr 01
2024
|
Nikolaos P. Nanis Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,232
+1.7%
|
-
|
|
Mar 25
2024
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
7,500
-16.32%
|
$112,500
$15.06 P/Share
|
|
Mar 25
2024
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+14.03%
|
$15,000
$2.73 P/Share
|
|
Mar 18
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-3.55%
|
$15,000
$15.18 P/Share
|
|
Mar 05
2024
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
5,647
-14.32%
|
$79,058
$14.53 P/Share
|
|
Mar 04
2024
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
15,653
-29.46%
|
$219,142
$14.52 P/Share
|
|
Mar 04
2024
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
7,945
-12.33%
|
$111,230
$14.52 P/Share
|
|
Mar 04
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
12,468
-17.36%
|
$174,552
$14.52 P/Share
|
|
Mar 04
2024
|
Richard J Napolitano CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
3,765
-17.24%
|
$52,710
$14.52 P/Share
|